Your browser doesn't support javascript.
loading
Phase I Study of 99mTc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer.
Bragina, Olga; von Witting, Emma; Garousi, Javad; Zelchan, Roman; Sandström, Mattias; Orlova, Anna; Medvedeva, Anna; Doroshenko, Artem; Vorobyeva, Anzhelika; Lindbo, Sarah; Borin, Jesper; Tarabanovskaya, Natalya; Sörensen, Jens; Hober, Sophia; Chernov, Vladimir; Tolmachev, Vladimir.
Affiliation
  • Bragina O; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • von Witting E; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk, Russia.
  • Garousi J; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology, and Health, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Zelchan R; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
  • Sandström M; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Orlova A; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk, Russia.
  • Medvedeva A; Radiology and Nuclear Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Doroshenko A; Medical Physics, Uppsala University Hospital, Uppsala, Sweden.
  • Vorobyeva A; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk, Russia.
  • Lindbo S; Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden; and.
  • Borin J; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Tarabanovskaya N; Department of General Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Sörensen J; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk, Russia.
  • Hober S; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
  • Chernov V; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology, and Health, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Tolmachev V; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology, and Health, KTH Royal Institute of Technology, Stockholm, Sweden.
J Nucl Med ; 62(4): 493-499, 2021 04.
Article in En | MEDLINE | ID: mdl-32817142
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Tomography, Emission-Computed, Single-Photon / Receptor, ErbB-2 Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Nucl Med Year: 2021 Document type: Article Affiliation country: RUSSIA Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Tomography, Emission-Computed, Single-Photon / Receptor, ErbB-2 Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Nucl Med Year: 2021 Document type: Article Affiliation country: RUSSIA Country of publication: United States